Impact of megatherapy in children with high-risk Ewing's tumours in complete remission: A report from the EBMT Solid Tumour Registry

Bone Marrow Transplantation

Volumn 15, Issue 5, 1995, Pages 697-705

  Ladenstein, R ^a   Lasset, C ^a   Pinkerton, R ^a   Zucker, J M ^a   Peters, C ^a   Burdach, S ^a   Pardo, N ^a   Dollorso, G ^a   Coze, C ^a   Buclon, M ^a   Philip, T ^a   Hartmann, O ^a  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

Ewing's tumours; High risk

Indexed keywords

BUSULFAN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; PROCARBAZINE; VINCRISTINE; VINDESINE;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW METASTASIS; BONE MARROW TRANSPLANTATION; BONE METASTASIS; CANCER REGISTRY; CHILD; DATA ANALYSIS; DRUG FATALITY; DRUG TOXICITY; EWING SARCOMA; FEMALE; FEVER; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROECTODERM TUMOR; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; REMISSION; SURVIVAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMAN; INFANT; MALE; NEOPLASM METASTASIS; REGISTRIES; RISK FACTORS; SARCOMA, EWING'S; SUPPORT, NON-U.S. GOV'T; SURVIVAL ANALYSIS;

EID: 0029073772     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)